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Abstract
Purpose: The aim of the study was to assess the interobserver variability in chest computed
tomography (CT) and whole body 2-deoxy-2-[
18F]fluoro-D-glucose positron emission tomog-
raphy (FDG-PET) screening for distant metastases in head and neck squamous cell carcinoma
(HNSCC) patients.
Procedure: Chest CT and whole body FDG-PET of 69 HNSCC patients with high-risk factors
who underwent screening for distant metastases were analyzed. All scans were independently
read by two experienced radiologists or nuclear physicians who were blinded to the other
examinations and follow-up results.
Results: A kappa of 0.516 was found for assessment of size on CT. Kappa values for origin and
susceptibility of 0.406 and 0.512 for CT and 0.834 and 0.939 for PET were found, respectively.
The overall conclusions had a kappa of 0.517–0.634 for CT and 0.820–1.000 for PET.
Conclusions: In screening for distant metastases in HNSCC patients with high-risk factors, chest
CT readings had a reasonable to substantial agreement, while PET readings showed an almost
perfect agreement. These findings suggest that for optimal assessment in clinical practice, PET
most often can be scored by one observer, but CT should probably more often be scored by
different observers in consensus or combined with PET.
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Introduction
H
ead and neck squamous cell carcinomas (HNSCC)
grow locally invasive and have a proclivity to
metastasize to regional lymph nodes rather than to spread
hematogenously. However, the presence of distant metasta-
ses influences prognosis and choice of treatment in patients
with HNSCC. Patients with HNSCC and distant metastases
are generally not considered curable and are treated mostly
palliatively.
In both clinical and autopsy studies, the lungs are the
most frequent site of distant metastases in patients with head
and neck cancer [1–3]. Moreover, lung metastases occur in
61–91% in combination with distant metastases at other
sites. Distant metastases at other sites without simultaneous
lung metastases are found in only 6–25% [2]. Because of the
high incidence of lung metastases and the frequent combi-
nation of distant metastases at other sites, examination of the
thorax is most important in screening for distant metastases. Correspondence to: Remco de Bree; e-mail: r.bree@vumc.nlThe diligence with which technique the lungs should be
screened remains controversial. Computed tomography (CT)
is more sensitive in the detection of pulmonary nodules than
plain chest radiography, because of the superiority of CT in
detecting small nodules [1, 4, 5].
In a previous study, it was concluded that chest CT was the
single most important diagnostic technique for pretreatment
screening for distant metastases [1]. However, despite negative
screening by chest CT and locoregional tumour control some
patients develop distant metastases [6]. These distant meta-
stases must have been present at diagnostic work-up, but were
apparently below the detection limit of screening tests.
In screening for distant metastases second primary
tumours can occasionally be detected at the same time, a
potential secondary gain in this group of patients. Second
primary tumours also have impact on survival and may alter
the selection of therapy in HNSCC patients. The cumulative
risk for second primary tumours in HNSCC patients is 3%
per year. Synchronous second primary tumours are diag-
nosed in about 4% of the HNSCC patients. Although the
head and neck region is the most frequent site, synchronous
primary tumours also occur below the clavicles: lungs,
oesophagus and other sites [7]. Therefore, the detection of
second primary tumours during initial work-up is important.
In a multicenter prospective study we found that whole
body positron emission tomography (PET) using the radio-
labelled glucose analog 2-deoxy-2-[
18F]fluoro-D-glucose
(FDG) has additional value in screening for distant metastases
andsecondprimary tumours,ifappliedtothe subsetofpatients
at substantial risk [8]. An assessment of imaging examinations
is usually based on a determination of their accuracy rates and
sensitivity and specificity values. However, the clinical utility
of an imaging study also depends on the reliability or the
consistencywithwhichthestudyisinterpretedinthesameway
by different observers. The consistency of observations made
bydifferent observers ininterpretingthesamestudies istermed
interobserver reliability or agreement. Although the accuracy
rates of CT and PET for screening on distant metastases in
HNSCC patients have been determined and compared in
several studies, the interobserver reliabilities of these diagnos-
tic techniques have not been measured. The extent to which
these accuracy results found by individual observers can be
generalised, and thereby foresee the applicability of CT and
PET for this patient group in daily clinical practice, tends to
depend on the degree of uniform reporting by different
observers. This study was performed to evaluate the interob-
server variability in reporting of CT and PET for screening on
distant metastases in HNSCC patients.
Materials and Methods
Chest CT and whole body FDG-PET of 69 HNSCC patients (18
women and 51 men) with high-risk factors who underwent
screening for distant metastases in our institute were analyzed.
The protocol was approved by the institutional ethics committee.
Since these examinations are performed in routine clinical practice
no informed consent was asked.
The mean age was 59 years and ranged from 40 to 81 years.
Primary tumour sites included the oral cavity (n=12), oropharynx
(n=25), hypopharynx (n=16), larynx (n=10), cervical oesophagus
(n=4) and lymph node metastases of unknown primary tumour (n=
12). Eight patients had two or more synchronous primary tumours.
Indications (based on palpation, CT, MRI, and/or ultrasound-
guided fine-needle aspiration cytology) for screening for distant
metastases were three or more lymph nodes metastases (n=8),
bilateral lymph metastases (n=19), lymph node metastases of 6 cm
or larger (n=16), low jugular lymph node metastases (n=2),
regional tumour recurrence (n=8) and second primary tumours (n
=21). Some patients had more than one indication for screening.
All were candidates for extensive treatment with curative intent:
surgery and/or radiotherapy with or without chemotherapy.
In 67 of the 69 patients a chest CT, which was performed to
screen for lung metastases, mediastinal lymph node metastases and
second primary bronchogenic carcinoma, was available for review.
Spiral CT scans were obtained with a fourth-generation Siemens
Somaton Plus (Siemens AG, Erlangen, Germany after intravenous
administration of contrast medium (Ultravist, Schering AG, Berlin,
Germany). Contiguous axial scanning planes were used with a
5-mm slice thickness without interslice gap. All images were
reviewed on PACS. Size was measured with manual electronic
measurement. The volume of intravenous contrast was 100 ml at
3 ml/s with a delay of 25 to 30 s. Radiological criteria for lung
metastases were: smoothly defined and subpleurally located
lesions, multiple and located at the end of a blood vessel; for
bronchogenic carcinoma, solitary, spiculated and centrally located
lesions; and for mediastinal lymph node metastases, a short axial
diameter of more than 10 mm [9].
All 67 chest CT scans were independently read by two experienced
radiologists (RPG, JHW) who were blinded to the other examinations
and follow-up results. On special forms location, long-axis diameter
(G1, 1–2, 2–3, 93c m ) ,o r i g i n( m e t a s t a s i s ,s econd primary, benign), and
a five-point ordinal Likert scale score (1=definitively benign, 2=
probably benign, 3=equivocal, 4=probably malignant, 5=definitely
malignant) of the most suspected lesions (with a maximum of 5) were
scored. Finally a conclusion had to be made for the presence (yes, no or
equivocal) of metastases or second primary tumour. Spiculations were
included in the determination of the long-axis diameter. If a nodule was
visible on several adjacent images, the largest diameter was selected.
All 69 patients underwent FDG-PET after a 6-h fast. At 90 min
after the intravenous administration of 10 mCi (370 MBq) FDG
imaging of the body (trajectory: knee-skull) was performed using a
dedicated PET scanner (Siemens HR plus). Any focal abnormality
suspicious for malignancy was reported. Although the primary goal
was screening for distant metastases, second primary tumours were
additionally scored as an event.
As with CT, PET images of the 69 patients were scored by two
independent experienced nuclear physicians (OSH, EFC). FDG
uptake was considered abnormal in cases of enhanced uptake
incompatible with its physiological biodistribution. The interpreters
used special forms to register the location and aspect (‘focal’ or
‘diffuse’) of lesions in PET scans, and to assign a Likert score to
grade their suspicion of malignancy (of the most suspected lesions).
Finally, a conclusion had to be drawn for the presence (yes, no
equivocal) of metastases or second primary tumour. The ‘aspect’ of
lesions was included since this is one of the elements that helps
with interpretation: areas of diffusely enhanced uptake are more
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between primary and secondary lesions can be difficult with PET;
in the present study the reviewers classified central pulmonary
lesions in PET scans as suspicious of primary tumours, and
peripheral lesions as metastases unless there were additional lesions
in PET scans (e.g. mediastinal foci) suggesting the presence of a
second primary tumour and its metastases. No standard uptake
value was calculated. No axis of a lesion was measured because,
PET does not reliably estimate tumour size.
The interobserver agreement was determined and expressed in a
weighted or unweighted kappa which corrects for agreement by
chance. The higher the kappa, the higher the agreement, with a
maximumof1.0: G0=noagreement,0.0–0.19=pooragreement,0.20–
0.39=fair agreement, 0.40–0.59=moderate agreement, 0.60–0.79=
substantial agreement, 0.80–1.00=almost perfect agreement [10].
In case of disagreement between the two observers a final
consensus reading was performed. Any change in scoring was
reported.
To correct for difference in scanning separate analysis was
performed for lesions inside the thorax. To examine the role of the
spatial resolution separate analysis was performed for lesions G1
and ≥1 cm (on CT scan).
Results
In 39 of the 67 patients, no suspected lesions were found by
chest CT. In the remaining 28 patients, a total number of 109
lesions on CT were scored (62 by observer 1 and 47 by
observer 2). In 43 of the 69 patients, no suspected lesions
were found by PET. In the remaining 26 patients a total
number of 94 lesions on PET were scored (47 by observer 1
and 47 by observer 2). The scorings of the observers and the
kappa values are shown in Table 1.
The kappa value for long-axis diameter on CT was 0.516
(95% confidence interval (CI) 0.357–0.675). For origin,
Likert scale score, malignancy, metastasis and second
primary tumour the values were 0.406 (95% CI; 0,277–
0.534), 0.512 (95% CI; 0.384–0.640), 0.634 (95% CI;
0.387–0.881), 0.523 (95% CI; 0.226–0.780) and 0.517
(95% CI; 0.236–0.798), respectively. The long-axis diameter
cannot be measured on PET. The kappa values for origin,
Likert scale score, malignancy, metastasis and second
primary tumour were 0.834 (95% CI; 0,699–0.969), 0.961
(95% CI; 0.909–1.000), 1.000 (95% CI; 1.000–1.000), 0.820
(95% CI; 0.648–0.992) and 0.826 (95% CI; 0.633–1.000),
respectively.
Initial disagreement in overall conclusions between the
examiners occurred in eight CT examinations. The exam-
iners could reach consensus in all cases. After consensus
reading, observer 1 changed his diagnosis five times: three
times from second primary to no malignant lesion and two
times from no malignancy to metastasis. Observer 2 changed
his diagnosis four times: two times from no malignancy to
metastasis, one time from equivocal to metastasis and one
time from metastasis to no malignancy.
Table 1. Scorings of the observers with interobserver agreement as kappa values
CT Kappa PET Kappa
Observer 1 Observer 2 Observer 1 Observer 2
Per lesion N=62 N=47 N=47 N=47
Long-axis diameter 0.516 N/A N/A N/A
G1c m 3 4 2 6
1–2c m 2 1 1 7
2–3c m 4 1




Metastasis 30 19 15 14
Second primary 9 12 11 11
Benign 23 16 21 22
Likert 0.512 0.939
Definitively benign 5 6 0 0
Probably benign 17 10 10 12
Equivocal 10 10 9 7
Probably malignant 13 12 21 21
Definitively malignant 17 9 7 7




Yes 13 10 15 15
No 54 57 54 54
Metastasis 0.523 0.820
Yes 8 6 11 9
Equivocal 6 6 3 4
No 53 55 55 56
Second primary tumour 0.517 0.826
Yes 6 6 7 8
Equivocal 2 3 2 2
No 59 58 60 59
aUnweighted kappa
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examiners occurred in five PET examinations. Also for PET
the examiners could reach consensus in all cases. After
consensus reading observer 1 changed his diagnosis three
times: two times from metastasis to second primary tumour
and one time from metastasis to unclear. Observer 2 changed
his diagnosis two times: both times from metastasis to
second primary tumour.
Lesions Outside CT Scanning Range
Seven lesions were observed outside of the thorax. Three
lesions were localized in the rectum and two lesions in the
colon. According to both observers, all of these lesions were
not suspicious for malignancy (focal polyps). One lesion
was localized in the liver. This lesion was scored as probably
malignant by both observers. One lesion was localized in the
lumbar spine and was scored as being definitively malignant
by both observers. If lesions outside of the thorax were left
out, the kappa for PET interobserver agreement were as
follows: origin 0.811 (95% CI; 0.637–0.985); Likert 0.971
(95% CI; 0.916–1.000); malignancy 1.000; metastases 0.740
(95% CI; 0.521–0.959) and second primary tumour 0.858
(95% CI; 0.698–1.000).
Nodules G10 mm
In a total of 18 patients, lesions G10 mm on CT were
reported. In 11 out of 18 patients in whom lesions G10 mm
were reported on CT no lesions were seen on PET (both
observers negative). For lesions G10 mm (as measured by
CT observer 1) the kappa values for CT interobserver
agreement were: origin 0.308 (95% CI; 0.009–0.606); Likert
0.411 (95% CI; 0.150–0.671); malignancy 0.558 (95% CI;
0.411–0.705); metastases 0.444 (95% CI; 0.156–0.733) and
second primary tumour 0.627 (95% CI; 0.383–0.870). For
PET these figures were 1.000 for all variables. For the other
lesions (≥10 mm) the kappa values for CT interobserver
agreement were: origin 0.535 (95% CI; 0.227–0.843); Likert
0.469 (95% CI; 0.178–0.760); malignancy 0.524 (95% CI;
0.387–0.661); metastases 0.509 (95% CI; 0.267–0.752) and
second primary tumour 0.339 (95% CI; 0.102–0.576). For
PET these figures were: origin 0.811 (95% CI; 0.659–
0.963); Likert 0.955 (95% CI; 0.894–0.1.000); malignancy
1.000; metastases 0.801 (95% CI; 0.630–0.972) and second
primary tumour 0.898 (95% CI; 0.784–1.000).
Discussion
To be consistently useful, interpretation of imaging tech-
niques must be reproducible. Ideally, both physicians with
and without special expertise in a particular area will provide
consistent interpretations. Although some accuracy data of
chest CT and PET in screening for distant metastases have
been determined and compared, the interobserver variability
of CT and PET has not been measured [1, 4–8, 11].
CT is extremely sensitive in the detection of pulmonary
nodules but is frequently indeterminate in diagnosis.
Increasing numbers of pulmonary nodules are being
detected, in large part due to the recent developments in
CT imaging techniques. While specific patterns of calcifica-
tion or the presence of fat in pulmonary nodules on CT can
be used to determine if a nodule is benign, most nodules lack
benign characteristics and are therefore considered indeter-
minate for malignancy. These non-calcified nodules repre-
sent a diagnostic challenge [12]. Interobserver agreement for
the detection of individual pulmonary nodules on CT is
reported to be relatively poor. Wormanns et al. [13] reported
that, of a total of 286 nodules, 103 nodules were found by
both readers. Leader et al. [14] scored 293 low-dose chest
CT scans as to their probability of being benign or malignant
nodule-based and examination based interobserver agree-
ment among the three radiologist was poor: highest kappa
values in paired comparison 0.120 and 0.458, respectively.
In the present study a substantial amount of agreement
(kappa 0.634) was found for scoring the presence or absence
of malignancy using CT, whereas the agreement for this
scoring was optimal (kappa 1.000) using PET. Also a five-
point ordinal Likert scale was used to classify the level of
susceptibility for malignancy. The interobserver agreement
for CT findings was moderate (kappa 0.512), whereas for
PET a high agreement (kappa 0.939) was found using five-
point ordinal scoring. These findings emphasize the diffi-
culty in interpretation of pulmonary nodules on CT. As with
CT, reading a PET scan requires weighing several factors to
arrive at a diagnostic probability. There is no mathematical
formula to cover them all. After detection, the interpretation
process of a lesion involves several observer-dependent
components, and this was one of the reasons for studying the
observer variation. In this study, we described and imple-
mented rules which are applied in our clinical practice. As in
the present study Joshi et al. [15] found a very high
interobserver agreement for the evaluation of pulmonary
nodules by PET as assessed with intraclass correlation
coefficients of 0.93 (range from 0 to 1). On PET images
lesions are more or less ‘present’ or ‘absent’ and therefore
probably less susceptible for variation in interpretation. In
the presented study this is reflected in the facts that PET
detected fewer lesions G10 mm, but the lesions which were
seen were scored with an optimal interobserver agreement
(kappa 1.0).
On CT, differentiation between a solitary pulmonary
metastases and a second primary bronchiogenic carcinoma
may be difficult. Therefore, most studies report on intra-
thoracic malignancies without separating metastases from
primary tumours. In the present study the origin of lesions
were scored by both CT and PET observers. The agreement
on origin for the CT observers was moderate (kappa 0.406)
and for PET observers high (kappa 0.834). Also the
agreement in overall conclusion if pulmonary metastases
were present was higher with PET as compared with CT
observers (kappa 0.820 versus 0.523, respectively). Also for
388 A. Senft, et al.: Interobserver Variability in Chest CT and Whole Body FDG-PETthe conclusion if a primary bronchiogenic carcinoma was
present or not, a higher interobserver agreement was found
for PET than CT (kappa 0.826 and 0.517, respectively).
Incertainclinicalsettings,accurateassessmentofthe sizeof
pulmonary nodules is important. In screening for distant
metastases not the size but the nature (benign or malignant)
and type (metastases or primary tumour) of the lesions are
important. Only for detection of growth of small equivocal
pulmonary nodules at follow-up suggestive of malignancy
exact size measurement is warranted. Reports describing
interobserver agreement for sizing nodules have been mixed.
Hopper et al. [16] evaluating interobserver variability in the
measurements of metastases to the lung and liver on CT
demonstrated statistically significant interobserver variability
of 15%. Bogot et al. [17] found a statistically significant
interobserver variability in measuring pulmonary nodule
v o l u m e s .R e v e le ta l .[ 18] found that both intra- and
interobserver agreement for measurement of nodule size
(long-axis diameter) on CT scans was poor. This is especially
true for irregular and poorly defined tumour foci [16]. On the
contrary, Wormanns et al. [13] assessed the interobserver
variability in size determination of pulmonary nodules at spiral
CT. In 23 patients with known pulmonary nodules diagnostic
confidence and size in exact size measurement and catego-
rization into three size classes (≤5, 6–10, 910 mm) were scored
by two observers. A good correlation (Pearson's correlation
coefficient 0.89–0.95) of measurements in millimetres was
found. A good interobserver agreement in categories (kappa
0.74) was reported [11]. In the present study, a moderate
amount (kappa 0.516) of agreement was found in categoriza-
tion of size classes using CT. This agreement may be slightly
different in newer generation CT scanners. In automated
volume measurementsinterobserver agreement islessrelevant.
In the present study, reading in consensus changed the
diagnosis (metastasis or second primary tumour) in 6% for
CT and 7% for PET. This implies that probably in a subset
of scans reading by two observers may be helpful.
In the present study in all categories the interobserver
agreement of PET was higher as compared with CT. PET
detected 47 lesions in 26 patients, while CT detected 69
lesions in 28 patients. Tumour size is an important
determinant of the ability of PET to detect smaller lung
malignancies. While no absolute size criteria is established,
it is generally accepted that lesions less than 10 mm are
predisposed to false negative results on PET due to limited
spatial resolution or low overall tumour volume. The limited
spatial resolution of PET together with nodule motion from
respiration at image acquisition may also impact the accurate
detection of small pulmonary nodules [19]. If visualized by
PET the nature of the lesion is probably less difficult to
determine than by CT, which depicts much smaller lesions.
Scoring CT is probably more difficult because more lesions
are visualized. It is anticipated that the use of newer
generation CT scanners and software, e.g. computer-aided
detection, yield an increase in detection of (small) lung
lesions [20]. These technical improvements may result in a
higher sensitivity. However, as is shown in this study, the
detection of smaller lesions is accompanied by a lower
interobserver agreement. Combined reading of CT and PET
may be helpful in lesions with a size that can theoretically be
visualized by PET. In those lesions PET can aid in adding
certainty in scoring the level of malignancy.
Because the data were acquired before PET-CT was widely
available and became the standard, in the present study stand-
alone PET rather than PET-CT has been used. However, we
think that the most findings are still of relevance. PET and CT
were compared in a head-to-head comparison. Even though
PET-CT is becoming more prevalent now, and some
comparative issues encountered with stand-alone systems will
be become less problematic, we feel that the first step of
interpretation of PET-CT images should be an independent
review of PET and CT. Combined readings thereafter will
allow a joint estimate of the probability of disease.
Conclusion
In screening for distant metastases in HNSCC patients with
high-risk factors chest CT readings had a reasonable to
substantial agreement for size, origin and susceptibility of
lesions, while PET readings showed an almost perfect
agreement for lesion characteristics. These findings suggest
that for optimal assessment in clinical practice PET most
often can be scored by one observer, but CT should probably
more often be scored by different observers in consensus or
combined with PET.
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